RA – Diagnosis, Manifestations, & Outcomes Poster III: Cardiopulmonary Aspects
Sunday, November 8, 2020
9:00 AM – 11:00 AM ET
Poster session.
Presentations:
9:00 AM – 11:00 AM ET
Associations of Walking Endurance and Speed with Multiple Measures of Subclinical Cardiovascular Disease in Rheumatoid Arthritis Genna Braverman – NY Presbyterian -- Columbia University Irving Medical Center
9:00 AM – 11:00 AM ET
Cardiovascular Risk Assessment with Carotid Ultrasonography in Addition to the Traditional Cardiovascular Risk Factor in Rheumatoid Arthritis: A Case Control Study Roxana González Mazarío, MD – Hospital La Fe (Valencia, Spain).
9:00 AM – 11:00 AM ET
External Validation of a Multi-biomarker-Based Cardiovascular Disease Risk Prediction Score for Rheumatoid Arthritis Patients Jeffrey R R. Curtis, MD, MS, MPH – University of Alabama at Birmingham
9:00 AM – 11:00 AM ET
Gains in Cardiovascular Risk Knowledge Through Web Based Educational Intervention for Rheumatoid Arthritis Patients Meenakshi Jolly, MD, MS – Rush University
9:00 AM – 11:00 AM ET
Increased Prevalence of Carotid Atherosclerosis in Postmenopausal Women with Rheumatoid Arthritis: A Case Control Study Mayra Alejandra Reyes Soto, -None- – Hospital Universitario, UANL
9:00 AM – 11:00 AM ET
Factors Associated with Incident Heart Failure Subtypes in Patients with Rheumatoid Arthritis Using Electronic Health Record Data Sicong Huang, MD, MS – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
In a Prospective RA Cohort, Higher Baseline Disease Activity Is an Independent Predictor of Decline in Left Ventricular Diastolic Function Elizabeth Park, MD – Columbia University Medical Center
9:00 AM – 11:00 AM ET
Performance of the MBDA-based CVD Risk Score in RA Patient Groups of Clinical Interest Jeffrey R R. Curtis, MD, MS, MPH – University of Alabama at Birmingham
9:00 AM – 11:00 AM ET
Red Cell Distribution Width and Absolute Lymphocyte Count Associate with Biomarkers of Inflammation and Subsequent Mortality in Rheumatoid Arthritis Sofi Damjanovska, MD – Case Western Reserve University
9:00 AM – 11:00 AM ET
Red Cell Distribution Width Is Associated with ASCVD Risk Score and CVD in RA After Initiation of Methotrexate Ibtissam Gad, MD – Case Western Reserve/ University Hospitals Cleveland Medical Center
9:00 AM – 11:00 AM ET
Serum Anti-malondialdehyde-acetaldehyde IgA Antibody Concentration Improves Prediction of Coronary Atherosclerosis Beyond Traditional Risk Factors in Patients with Rheumatoid Arthritis Hannah Lomzenski, MD – Vanderbilt University Medical Center
9:00 AM – 11:00 AM ET
Serum High-sensitive Cardiac Troponin at Baseline Predict Cardiovascular Events in Rheumatoid Arthritis and Osteoarthritis M. Elaine Husni, MD, MPH – Cleveland Clinic
9:00 AM – 11:00 AM ET
Sex Differences in Cardiovascular Disease Prevention in Patients with Rheumatoid Arthritis: World-wide Data from the SURF-RA Elena Myasoedova, MD, PhD – Mayo Clinic
9:00 AM – 11:00 AM ET
Specificity for Inflammatory Pathways Associated with Coronary Microvascular Dysfunction in Rheumatoid Arthritis brittany N. weber, MD, PhD – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
Subclinical Coronary Calcification Associated with Long-term Cardiovascular Outcomes in Rheumatoid Arthritis George A. Karpouzas, MD – Harbor-UCLA Medical Center
9:00 AM – 11:00 AM ET
Unsupervised Molecular Profile Clustering in the Serum of Rheumatoid Arthritis Patients Identifies Groups with Differential CV-risk SCORE: Modulation by Biological Therapies Maria Luque-Tevar, MSc – Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain
9:00 AM – 11:00 AM ET
MUC5B Promoter Variant rs35705950 and Risk Stratification for Rheumatoid Arthritis - Interstitial Lung Disease Pierre Antoine Juge – Hôpital Bichat-Claude Bernard, Service de Rhumatologie
9:00 AM – 11:00 AM ET
MUC5B rs35705950 and Rheumatoid Arthritis Associated Interstitial Lung Disease Progression Pierre Antoine Juge – Hôpital Bichat-Claude Bernard, Service de Rhumatologie
9:00 AM – 11:00 AM ET
Associations of Biological Sex with Interstitial Lung Disease in Patients with Rheumatoid Arthritis Are Independent of Other Known Risk Factors Austin Wheeler, MD – University of Nebraska Medical Center
9:00 AM – 11:00 AM ET
Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review Dawson Shaver, MD – University of Nebraska Medical Center
9:00 AM – 11:00 AM ET
Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease Among Patients with Rheumatoid Arthritis Vanessa L. Kronzer, MD – Mayo Clinic
9:00 AM – 11:00 AM ET
Prevalence of Subclinical Interstitial Lung Disease After a Mean Rheumatoid Arthritis Duration of 13 Years: Results from the French ESPOIR Cohort Pierre Antoine Juge – Hôpital Bichat-Claude Bernard, Service de Rhumatologie
9:00 AM – 11:00 AM ET
Serum Anti-PAD4 and Anti-PAD3/4XR Antibodies in Rheumatoid Arthritis Associated-Interstitial Lung Disease Are Associated with Better Lung Function Timothy Wilson, MD – University of Colorado